Science Current Events | Science News | Brightsurf.com
 

Extra-aggressive form of idiopathic pulmonary fibrosis identified

May 30, 2007
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disorder from which most patients die within 5 years after diagnosis. The disease is characterized by the insidious onset of dyspnea or cough and usually evolves slowly.

Now, Selman and coworkers present in an article published in the online, open-access journal PLoS ONE on Wednesday 30th May, strong evidence indicating that a subset of IPF patients has a short duration of symptoms before diagnosis and display an accelerated clinical course to end-stage disease. The authors postulate that these "rapid progressor" patients, predominantly smoking males, represent a distinct clinical phenotype compared with the usual "slow progressors" patients.

"These findings highlight the variability in the progression and outcome of IPF, and may explain, in part, the difficulty in obtaining significant and reproducible results in studies of therapeutic interventions in patients with IPF," said Dr Selman, who is the Director of Research at the National Institute of Respiratory Research in Mexico City and the lead author on this publication. "They also suggest that physicians should pay more attention to the time of onset of symptoms, and to look for other signs that allow the identification of these rapid progressor patients".

In this study the authors performed global gene expression analysis and other molecular studies in a subset of patients and identified a number of genes that were differentially expressed in both groups, suggesting that rapid progressors are biologically distinct from slow progressors.

"While preliminary, these results may allow investigators to identify biomarkers of disease progression," said Dr King, who is the Chief of Medicine at San Francisco General Hospital and an internationally renowned expert in research and management of pulmonary fibrosis.

The senior author on this paper, Dr Naftali Kaminski, who is the Director of the Simmons Center for Interstitial Lung Disease at the University of Pittsburgh, added that this research highlighted the need to collect as much information on patients with IPF as possible. "We are only now starting to really understand the disease and characterize it," he said, "therefore, it is critical for patients with the disease to be seen in centers that are actively involved in IPF research."

Better identification and understanding of these differences may provide insights into the pathogenesis of IPF and assist in the development of therapeutic interventions for this devastating lung disease.

Public Library of Science


Related Pulmonary Fibrosis Current Events and Pulmonary Fibrosis News Articles


Mutations linked to repair of chromosome ends may make emphysema more likely in smokers
Mutations in a gene that helps repair damaged chromosome ends may make smokers -- especially female smokers -- more susceptible to emphysema, according to results of a new study led by Johns Hopkins Kimmel Cancer Center researchers.

Suppressing a protein reduces cancer spread in mice
Scientists have found that decreasing the levels of or blocking a specific protein commonly found in humans and many other animals allowed them to slow the spread of two different kinds of cancer to the lungs of mice.

Fat a culprit in fibrotic lung damage
Pulmonary fibrosis has no cure. It's caused by scarring that seems to feed on itself, with the tougher, less elastic tissue replacing the ever moving and stretching lung, making it increasingly difficult for patients to breathe.

Jackson Laboratory researchers discover lung regeneration mechanism
A research team led by Jackson Laboratory Professors Frank McKeon, Ph.D., and Wa Xian, Ph.D., reports on the role of certain lung stem cells in regenerating lungs damaged by disease.

Reversing the effects of pulmonary fibrosis
Yale University researchers are studying a potential new treatment that reverses the effects of pulmonary fibrosis, a respiratory disease in which scars develop in the lungs and severely hamper breathing.

Idiopathic pulmonary fibrosis cases linked with asbestos exposure
A proportion of idiopathic pulmonary fibrosis (IPF) cases may be linked with asbestos exposure, according to the results of a new study.

Longer telomeres linked to risk of brain cancer
New genomic research led by UC San Francisco (UCSF) scientists reveals that two common gene variants that lead to longer telomeres, the caps on chromosome ends thought by many scientists to confer health by protecting cells from aging, also significantly increase the risk of developing the deadly brain cancers known as gliomas.

Toxins in the environment might make you older than your years
Why are some 75-year-olds downright spry while others can barely get around? Part of the explanation, say researchers writing in the Cell Press journal Trends in Molecular Medicine on May 28, is differences from one person to the next in exposure to harmful substances in the environment, chemicals such as benzene, cigarette smoke, and even stress.

X-ray dark-field radiography provides detailed imaging of lung diseases
Scientists at the Helmholtz Zentrum München (HMGU) working in cooperation with the Ludwig-Maximilians-Universität Hospital and the Technische Universität München (TUM) have for the first time tested X-ray dark-field radiography on a living organism to diagnose lung disease.

Studies published in NEJM identify promising drug therapies for fatal lung disease
Researchers in separate clinical trials found two drugs slow the progression of idiopathic pulmonary fibrosis, a fatal lung disease with no effective treatment or cure, and for which there is currently no therapy approved by the Food and Drug Administration.
More Pulmonary Fibrosis Current Events and Pulmonary Fibrosis News Articles

Pulmonary Fibrosis: Coping With a Terminal Disease

Pulmonary Fibrosis: Coping With a Terminal Disease
by Lifestyle Design Solutions


Pulmonary Fibrosis: Coping With a Terminal Disease by Robert Post

What do you do when you learn you have Pulmonary Fibrosis, a terminal disease for which there is presently no cure? The author relates his personal experience and explains how he has learned to cope with the disease, products and methods he uses for maintaining health and combating progression of the disease and explains how you can, too.

A linked resources section gives advice on finding and using support groups and Pulmonary Rehabilitation programs. Products and sources are identified that the author has found to be beneficial or vital for health maintenance.

This publication contains frank material that some may find disturbing to read but the author feels the patient and their caregiver...

Breathing Should Never Be Hard Work: One Man's Journey with Idiopathic Pulmonary Fibrosis

Breathing Should Never Be Hard Work: One Man's Journey with Idiopathic Pulmonary Fibrosis
by Robert Davidson (Author)


Robert Davidson was diagnosed with Idiopathic Pulmonary Fibrosis in October 2007 after having difficulties with the fitness test necessary to retain senior level soccer referee status. Rather than give in to the disease and die, he decided to fight and live as normal a life as possible, borrowing from Winston Churchill, the mantra "Never surrender". He and his wife, Heather, believe it was this attitude that led to him "winning" a double lung transplant January 30, 2010, just weeks before he would have died from the disease. This book is about his journey with that life threatening disease. Although it "steals away the sufferer's breath" Robert travelled to China (finding 12,800 feet up the Himalayas too high) and to the highlands of Scotland for his wife's 60th birthday celebration. ...

Journey of the CareGiver: Battling Pulmonary Fibrosis

Journey of the CareGiver: Battling Pulmonary Fibrosis
by MS, Lois Moody RN (Author)


The latest edition of this book (Surviving Caregiving) is available for the same price at: www.amazon.com/Surviving-Caregiving-Challenges-Lois-Moody/dp/1501029878/ref=sr_1_4?ie=UTF8&qid=1410298234&sr=8-4&keywords=surviving+caregiving

Improving Fibrosis in 30 Days

Improving Fibrosis in 30 Days
by Naturally Healthy Publications


Improving Fibrosis in 30 Days includes a rehabilitation plan to improve your pulmonary fibrosis symptoms and to attain long term health.

First Aid for the USMLE Step 1 2015 (First Aid USMLE)

First Aid for the USMLE Step 1 2015 (First Aid USMLE)
by Tao Le (Author), Vikas Bhushan (Author)


THE 25th EDITION OF THE WORLD'S MOST POPULAR MEDICAL REVIEW BOOK! Trust 25 years of experience for the most effective USMLE Step 1 preparation possible 1,250+ must-know topics provide a complete framework for your USMLE preparation Test-taking advice with focus on high-efficiency studying Major revisions in all subject areas based on feedback from thousands of students Free real-time updates and corrections at www.firstaidteam.com Extensive faculty review process with nationally known USMLE instructors 1,000+ color photos and diagrams help you visualize high-yield concepts Expanded guide to high-yield study resources, including mobile apps INSIDER ADVICE FOR STUDENTS FROM STUDENTS

Improving Lung Health in 30 Days: Pulmonary Rehabilitation Plan for COPD, Emphysema, Fibrosis, Bronchiectasis and More

Improving Lung Health in 30 Days: Pulmonary Rehabilitation Plan for COPD, Emphysema, Fibrosis, Bronchiectasis and More
by Robert Redfern (Author)


Improving Lung Health in 30 Days includes a rehabilitation plan to recover lung health and improve pulmonary conditions such as bronchitis, bronchiectasis, COPD, cystic fibrosis and emphysema amongst others.

Ruppel's Manual of Pulmonary Function Testing, 10e (Manual of Pulmonary Function Testing (Ruppel))

Ruppel's Manual of Pulmonary Function Testing, 10e (Manual of Pulmonary Function Testing (Ruppel))
by Carl Mottram BA RRT RPFT FAARC (Author)


Covering common pulmonary function tests and techniques, Ruppel's Manual of Pulmonary Function Testing, 10th Edition is not only an authoritative, on-the-job reference, but an excellent resource for preparing for the CPFT (certified pulmonary function technologist) and RPFT (registered pulmonary function technologist) specialty credentialing examinations. It includes information on pathophysiology, equipment, and quality assurance, so you can develop the testing skills you need to find and assess lung abnormalities and conditions including asthma, chronic bronchitis, emphysema, and cystic fibrosis. Written by Carl Mottram, RRT, RPFT, FAARC, one of the most respected experts in pulmonary function procedures, this text helps you get accurate test results every time.Case studies provide...

The Official Patient's Sourcebook on Idiopathic Pulmonary Fibrosis

The Official Patient's Sourcebook on Idiopathic Pulmonary Fibrosis
by James N. Parker (Author)


This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to idiopathic pulmonary fibrosis (also alveolocapillary block; cryptogenic fibrosing alveolitis; diffuse fibrosing alveolitis; fibrosing alveolitis; Hamman-Rich syndrome; idiopathic diffuse interstitial pulmonary fibrosis), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various...

Respiratory Physiology: The Essentials (RESPIRATORY PHYSIOLOGY: THE ESSENTIALS (WEST))

Respiratory Physiology: The Essentials (RESPIRATORY PHYSIOLOGY: THE ESSENTIALS (WEST))
by John B. West MD PhD (Author)


Widely considered the gold standard for the teaching and learning of respiratory physiology, this fully updated Ninth Edition includes key points for each chapter and multiple-choice review questions and answers with full explanations. Available online via thePoint, animations help to clarify particularly difficult concepts and provide a visual component for use during instruction or review. --NEW Presents rationales for all questions, as well as explanations for each answer choice--Provides 82 essential-to-know, multiple-choice review questions which appear at the end of each chapter--Features an Appendix of important equations--Supports learning through chapter-opening learning objectives and introductory material, as well as Key Concepts summaries at the end of each chapter--Includes...

Pulmonary Pathophysiology: The Essentials (PULMONARY PATHOPHYSIOLOGY (WEST))

Pulmonary Pathophysiology: The Essentials (PULMONARY PATHOPHYSIOLOGY (WEST))
by John B. West MD PhD (Author)


This companion monograph to West's Respiratory Physiology covers normal respiratory function and focuses on the function of the diseased lung. Pulmonary Pathophysiology: The Essentials offers a concise overview of the diseased states of the lung, emphasizing structure and function. The Eighth Edition is updated to include new information on asthma therapies, new radiographs and micrographs, extended sections on infections and cancer, more thorough explanations for review questions, and a new summary appendix of equations with sample calculations.

© 2015 BrightSurf.com